Table 2.
Isolates | Salt tolerance assay | lysozyme tolerance assay | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Survival rate (CFU/ml) | Survival rate (CFU/ml) | ||||||||||
Control (0%) | 2% | 4% | 6% | 8% | 10% | Control | 50 µg/ml | 100 µg/ml | |||
PUFSTP35 | 8.18 ± 0.03c | 8.37 ± 0.06b | 8.46 ± 0.02ab | 8.48 ± 0.03a | 8.25 ± 0.02c | 7.96 ± 0.04d | 8.12 ± 0.03a | 7.37 ± 0.04a | 6.12 ± 0.03b | ||
PUFSTP38 | 8.39 ± 0.02a | 8.37 ± 0.09b | 8.26 ± 0.01b | 8.26 ± 0.01b | 8.42 ± 0.01a | 7.82 ± 0.01c | 8.30 ± 0.03a | 7.29 ± 0.03a | 6.30 ± 0.03a | ||
PUFSTP39 | 8.06 ± 0.03b | 8.18 ± 0.11ab | 8.08 ± 0.04ab | 8.21 ± 0.04a | 8.18 ± 0.03ab | 7.70 ± 0.01c | 8.39 ± 0.01a | 7.45 ± 0.02b | 7.39 ± 0.02c | ||
PUFSTP44 | 8.39 ± 0.01bc | 8.46 ± 0.02a | 8.38 ± 0.01c | 8.42 ± 0.06b | 8.05 ± 0.01d | 7.68 ± 0.03e | 7.87 ± 0.01a | 6.65 ± 0.56b | 6.64 ± 0.01c | ||
PUFSTP70 | 8.61 ± 0.18b | 8.83 ± 0.03a | 8.64 ± 0.02ab | 8.48 ± 0.04bc | 8.35 ± 0.02c | 8.13 ± 0.02d | 8.51 ± 0.02a | 7.53 ± 0.04a | 7.51 ± 0.06a | ||
PUFSTP71 | 8.37 ± 0.02ab | 8.56 ± 0.23a | 8.38 ± 0.01ab | 8.37 ± 0.03ab | 8.24 ± 0.00b | 7.77 ± 0.01c | 8.47 ± 0.04a | 8.55 ± 0.01a | 7.47 ± 0.02c | ||
PUFSTP74 | 8.70 ± 0.03b | 8.76 ± 0.01a | 8.66 ± 0.02c | 8.45 ± 0.02d | 7.70 ± 0.00e | 7.68 ± 0.04e | 8.24 ± 0.05a | 7.57 ± 0.02a | 7.24 ± 0.05b | ||
PUFSTP81 | 8.69 ± 0.01b | 8.79 ± 0.00a | 8.63 ± 0.04c | 8.49 ± 0.01d | 8.39 ± 0.01e | 7.83 ± 0.02f | 8.22 ± 0.02a | 7.22 ± 0.04b | 6.53 ± 0.06c | ||
SS1 | 8.31 ± 0.01b | 8.46 ± 0.03a | 8.34 ± 0.02b | 7.36 ± 0.01c | 6.71 ± 0.01d | 6.74 ± 0.01d | 8.51 ± 0.03a | 7.57 ± 0.01b | 6.50 ± 0.02c |
The presented values are the means of three determinations (n = 3), with standard deviations for each column, different superscript letters differ significantly (p ≤ 0.05) by 2-sided Tukey’s HSD
The superscripts denote statistically significant values obtained by 2-sided Tukey analysis using SPSS program